Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
18.81
36.84
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Zhejiang Shouxiangu Pharmaceutical Co Ltd
Zhejiang Shouxiangu Pharmaceutical Co Ltd
Tax Provision
Zhejiang Shouxiangu Pharmaceutical Co Ltd
Tax Provision Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
|
Tax Provision
-¥22k
|
CAGR 3-Years
79%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
|
|
Hengan International Group Company Ltd
HKEX:1044
|
Tax Provision
-¥816m
|
CAGR 3-Years
13%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
|
Proya Cosmetics Co Ltd
SSE:603605
|
Tax Provision
-¥289.7m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
|
Tax Provision
-¥109.6m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
By-health Co Ltd
SZSE:300146
|
Tax Provision
-¥417.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
Tax Provision
-¥296.9m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zhejiang Shouxiangu Pharmaceutical Co Ltd
Glance View
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the breeding, cultivation, processing, and sale of Chinese herbal pieces and health food. The company is headquartered in Jinhua, Zhejiang and currently employs 1,026 full-time employees. The company went IPO on 2017-05-10. The firm's main products include ganoderma lucidum spore powder, Tiepi Fengdou granule, ganoderma extract products and fresh dendrobium officinales, among others. The firm mainly operates its businesses in domestic markets through wholesaling and direct sales.
See Also
What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's Tax Provision?
Tax Provision
-22k
CNY
Based on the financial report for Sep 30, 2024, Zhejiang Shouxiangu Pharmaceutical Co Ltd's Tax Provision amounts to -22k CNY.
What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's Tax Provision growth rate?
Tax Provision CAGR 5Y
61%
Over the last year, the Tax Provision growth was 92%. The average annual Tax Provision growth rates for Zhejiang Shouxiangu Pharmaceutical Co Ltd have been 79% over the past three years , 61% over the past five years .
You don't have any saved screeners yet
